Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C, Gastroenterology, vol.122, pp.1303-1313, 2002. ,
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label followup study, Lancet, vol.381, pp.468-475, 2013. ,
Reversibility of hepatic fibrosis in treated genetic hemochromatosis: A study of 36 cases, Hepatology, vol.44, pp.472-477, 2006. ,
Screening for hemochromatosis in asymptomatic subjects with or without a family history, Arch Intern Med, vol.166, pp.294-301, 2006. ,
Reversibility of hepatic fibrosis in autoimmune hepatitis, Annals of Internal Medicine, vol.127, pp.981-985, 1997. ,
Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment, Annals of Internal Medicine, vol.126, pp.682-688, 1997. ,
Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients, Gastroenterology, vol.149, pp.379-88, 2015. ,
Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis, Arch Pathol Lab Med, vol.124, pp.1599-607, 2000. ,
Clinical evidence for the regression of liver fibrosis, Journal of Hepatology, vol.56, pp.1171-1180, 2012. ,
Noninvasive prediction of cirrhosis in C282Y-linked hemochromatosis, Hepatology, vol.36, pp.673-681, 2002. ,
Iron-overload-related disease in HFE hereditary hemochromatosis, N Engl J Med, vol.358, pp.221-251, 2008. ,
Decreased cardiovascular and extrahepatic cancer-related mortality in treated patients with mild HFE hemochromatosis, J Hepatol, vol.62, pp.682-691, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01091479
Clinically overt hereditary hemochromatosis in Denmark 1948-1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients, Ann Hematol, vol.80, pp.737-781, 2001. ,
Long term results of venesection therapy in idiopathic haemochromatosis, Q J Med, vol.45, pp.611-634, 1976. ,
Long-term survival in patients with hereditary hemochromatosis, Gastroenterology, vol.110, pp.1107-1119, 1996. ,
Cirrhosis reversal: a duel between dogma and myth, J Hepatol, vol.40, pp.860-867, 2004. ,
Portal hypertension and iron depletion in patients with genetic hemochromatosis, Hepatology, vol.22, pp.1127-1131, 1995. ,
Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C, Gastroenterology, vol.122, pp.1303-1316, 2002. ,
Impact of interferon-alpha therapy on liver fibrosis progression in patients with HBeAg-negative chronic hepatitis B, J Viral Hepat, vol.12, pp.199-206, 2005. ,
Sources of variability in histological scoring of chronic viral hepatitis, Hepatology, vol.41, pp.257-64, 2005. ,
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection, Am J Gastroenterol, vol.97, pp.2614-2622, 2002. ,
Direct and indirect evidence for the reversibility of cirrhosis, Hum Pathol, vol.37, pp.1519-1545, 2006. ,
The Laennec staging system for histological subclassification of cirrhosis is useful for stratification of prognosis in patients with liver cirrhosis, J Hepatol, vol.57, pp.556-63, 2012. ,
Elevated serum alanine aminotransferase and gammaglutamyltransferase and mortality in the United States population, Gastroenterology, vol.136, pp.477-85, 2009. ,
Insulin Resistance is Associated With Significant Liver Fibrosis in Chronic Hepatitis C Patients: A Systemic Review and Meta-Analysis, J Clin Gastroenterol, vol.50, pp.80-84, 2016. ,
Clinical cofactors and hepatic fibrosis in hereditary hemochromatosis: the role of diabetes mellitus, Hepatology, vol.56, pp.904-915, 2012. ,
Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis, Clin Gastroenterol Hepatol, vol.5, pp.1-4, 2007. ,
Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications, Gastroenterology, vol.152, pp.142-156, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01447065
Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis, J Hepatol, vol.52, pp.652-659, 2010. ,